Palisade Bio, Inc.
PALI • NASDAQ
Palisade Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO J. D. Finley, with a market cap of $469.3M.
Market Cap$469.3M
Employees9.0
CEOJ. D. Finley
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
Palisade Bio, Inc. FAQ
Common questions about Palisade Bio, Inc.
Palisade Bio, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026 after market close.
Palisade Bio, Inc. has approximately 9 employees.